Venn Life Sciences

(Image: iStock/ernardaSv)

CRO Venn Life Sciences inks €2.5m deal

By Melissa Fassbender

Venn Life Sciences has signed a new contract with Sedana Medical AB worth €2.5m as the CRO continues to reposition itself for growth.

Venn Life Sciences is a European CRO providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology, medical device and academic organisations. (Image: iStock/RomoloTavani)

Growing CRO eyes further expansion

By Melissa Fassbender

With a new contract signed worth €2.8m ($3.13m), the growing contract research organization (CRO), Venn Life Sciences, is eyeing future expansion.

Cardinal’s performance will be under particular scrutiny as the company in the last fiscal year recorded a loss before tax of €444,000

Venn acquires part of French CRO for about €500k

By Zachary Brennan

In its third acquisition in the past 10 months, European CRO (contract research organization) Venn Life Sciences has acquired Cardinal Systems, a France-based CRO specialising in data management and randomisation systems.

Venn buys human skin substitute

Venn buys human skin substitute

By Fiona BARRY

Clinical research group Venn Life Sciences has acquired the rights to LabSkin (pictured), a human skin substitute that behaves like the real thing, from dermatology CRO Evocutis.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers